Alnylam Pharmaceuticals
ALNY
#820
Rank
โ‚น2.899 T
Marketcap
โ‚น21,670
Share price
1.84%
Change (1 day)
-45.98%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Quarterly Reports

Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q4

Quarterly Report 2025-q4

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2022-q1

Quarterly Report 2022-q1

Language: English

View Quarterly Report